Most Accessed Articles
Temozolomide: Mechanisms of Action, Repair and Resistance
, 2012; 5(1): 102-114.Jihong Zhang, Malcolm F.G. Stevens and Tracey D. Bradshaw
DOI: 10.2174/1874467211205010102
ENaC Inhibitors and Airway Re-hydration in Cystic Fibrosis: State of the Art
, 2013; 6(1): 3-12.Mike Althaus
DOI: 10.2174/18744672112059990025
Treatment of Pulmonary Edema by ENaC Activators/Stimulators
, 2013; 6(1): 13-27.Martin Fronius
DOI: 10.2174/1874467211306010003
Opioids in the Frame of New Psychoactive Substances Network: A Complex Pharmacological and Toxicological Issue
, 2018; 11(2): 97-108.Ludovic Ventura, Felix Carvalho and Ricardo Jorge Dinis-Oliveira*
DOI: 10.2174/1874467210666170704110146
Decoding Corticotropin-Releasing Factor Receptor Type 1 Crystal Structures
, 2017; 10(4): 334-344.Andrew S. Dore, Andrea Bortolato, Kaspar Hollenstein, Robert K.Y. Cheng, Randy J. Read and Fiona H. Marshall*
DOI: 10.2174/1874467210666170110114727
FK506-Binding Proteins and Their Diverse Functions
, 2016; 9(1): 48-65.Mingming Tong and Yu Jiang
DOI: 10.2174/1874467208666150519113541
The CRF Family of Neuropeptides and their Receptors - Mediators of the Central Stress Response
, 2018; 11(1): 4-31.Nina Dedic, Alon Chen* and Jan M. Deussing
DOI: 10.2174/1874467210666170302104053
Biochemical, Molecular and Epigenetic Mechanisms of Valproic Acid Neuroprotection
, 2009; 2(1): 95-109.Barbara Monti, Elisabetta Polazzi and Antonio Contestabile
DOI: 10.2174/1874467210902010095
Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists
, 2018; 11(2): 113-121.Yi Zhao, Kaijin Wu, Yongfeng Wu, Elizabeth Melendez, Goar Smbatyan, David Massiello and Michael Kahn*
DOI: 10.2174/1874467210666170919155739
Webmaster Contact: info@benthamscience.org